Stephen Kinnock MP: speeches

Speeches

• 21 Oct 2025 · Topical Questions · Hansard source

  More

  I do not know the details of that case, but if the hon. Gentleman writes to me, I can certainly come back to him on it. That sounds like a vital service that needs to be protected.

• 21 Oct 2025 · Topical Questions · Hansard source

  More

  As my hon. Friend will know, the consultation closed on 19 August. We are now considering the outcomes, and expect to publish a response very shortly. These reforms will improve support for patients with complex or urgent needs by better incentivising dentists to deliver this care on the NHS.

• 21 Oct 2025 · Topical Questions · Hansard source

  More

  I thank the hon. Member for that question. He will have seen that, in the 10-year plan, we have committed to tie-ins. Once the current cohort is through its studies, new cohorts will be tied into doing NHS dentistry for a period after graduation. I am sure that he welcomes that very important measure.

• 21 Oct 2025 · Topical Questions · Hansard source

  More

  As I have pointed out, we are providing unprecedented levels of funding for hospices, but there is clearly a challenging fiscal position. I note that in their manifesto the Liberal Democrats proposed to spend only an extra £8 billion on health and care, whereas we have invested £26 billion. Before calling for more spending, they should tell us what they would cut.

• 21 Oct 2025 · Topical Questions · Hansard source

  More

  I did not hear the hon. Gentleman welcome the fact that we provided £100 million—an unprecedented amount—in capital funding for hospices, and £26 million a year and £80 million over three years for children’s hospices. We recognise that hospices benefit from being rooted in their communities, with amazing charity and philanthropy support, but of course we know that the Government need to do their bit as well, and that is precisely what we were doing. I was very pleased to visit Noah’s Ark children’s hospice in Barnet last week and to speak to the chief executive, who warmly welcomed the stability and certainty that the three-year allocation has provided.

• 21 Oct 2025 · Hospital to Community Care · Hansard source

  More

  The Darzi investigation found that NHS resources are too focused on hospitals at the expense of community care. Our reforms will turn the NHS into more of a neighbourhood health service. We have already recruited an extra 2,000 more GPs, we are rolling out 700,000 extra dental appointments, and we have agreed a new contract of investment and reform for community pharmacy. As part of our 10-year plan, we will be rolling out neighbourhood health centres across the country, starting with the places that are in the greatest need.

• 21 Oct 2025 · Hospital to Community Care · Hansard source

  More

  I thank my hon. Friend for that question, and congratulate him on his work campaigning on this issue. Regular support and advice from a Parkinson’s disease nurse specialist is highlighted as a key intervention in the National Institute for Health and Care Excellence guidelines on Parkinson’s disease in adults. The forthcoming 10-year workforce plan will support the 10-year health plan by addressing workforce shortages and skills gaps. This will be crucial to delivering quality and accessible care for those with Parkinson’s.

• 21 Oct 2025 · Hospital to Community Care · Hansard source

  More

  I thank the right hon. Gentleman for his question. I am not familiar with the details of that case, but if he would not mind writing to me, I would be very happy to take that issue forward. He is right that there is a mountain to climb, not least because of the mess that was left to us by the previous Government, but we are climbing that mountain step by step. The 10-year plan is a big step in the right direction; it is now all about delivery, and that is what we are doing every day.

• 21 Oct 2025 · Employer’s National Insurance: GPs · Hansard source

  More

  Thanks to the decisions taken by the Chancellor at the Budget, we are investing an extra £1.1 billion in general practice—the biggest increase in a decade. That funding has allowed us to recruit an extra 2,000 GPs, agree a contract for the first time in four years, and introduce online access. Does the hon. Member welcome that investment, or would she cut it?

• 21 Oct 2025 · Employer’s National Insurance: GPs · Hansard source

  More

  Again, I find it extraordinary that Conservative Members have the brass neck to ask those kinds of questions. They created the mess, and now they are criticising us—it is a bit like the arsonists heckling the firefighters. Patient satisfaction in general practice has risen from 67% last year to 75% this year, and the proportion of patients reporting difficulty contacting their practice has fallen from 18.7% in July 2024 to 10.6% in May 2025. We are just getting started, and I did not hear the hon. Lady welcome the investment.

• 21 Oct 2025 · Virtual Wards · Hansard source

  More

  I welcome the Chair of the Select Committee back from parental leave and greatly look forward to working with her again. Virtual wards allow patients to get hospital-level care in the comfort of their own home, speeding up their recovery while freeing up hospital beds for the patients who need them most. We are rolling out virtual wards further, so that they become the norm for managing many conditions at home.

• 21 Oct 2025 · Virtual Wards · Hansard source

  More

  The hon. Lady makes a very valid point: this is about the shift from hospital to community, which we have to drive forward. In September 2025, 12,522 virtual ward beds were available—an increase from 12,497 in September 2024. Slowly but surely, we are increasing the number of virtual ward beds and the capability of virtual wards, but there is still a long way to go. I absolutely accept the point that the hon. Lady makes.

• 21 Oct 2025 · Children’s Hospices: Ringfenced Funding · Hansard source

  More

  Children’s hospices provide crucial support, but for too long they have faced the cliff edge of annual funding cycles. I am really proud that we have provided certainty with a three-year funding settlement of £80 million, giving children’s hospices the stability and predictability they need to plan properly and focus on caring for seriously ill children and their families and loved ones. I am sure that the hon. Member will join me in welcoming the certainty that we have delivered for the sector.

• 21 Oct 2025 · Children’s Hospices: Ringfenced Funding · Hansard source

  More

  I am delighted that Julia’s House hospice received £525,000 from the allocation. I am sure that was very welcome to the staff and the families. It is also worth noting that, of the £100 million allocation that we made to capital funding, £12 million went to children’s hospices. That is an increase on top of what we have just been talking about. Of course, there are challenging times for funding, but we have also provided the sector with a huge amount of certainty and stability.

• 21 Oct 2025 · Children’s Hospices: Ringfenced Funding · Hansard source

  More

  I find it quite extraordinary that Opposition Members come to this House and lecture us on the sustainability of funding, given the way in which they crashed the economy and left us in a dire fiscal position. I would have hoped that the hon. Gentleman would welcome the fact that, rather than the annual funding cliff edge that they left for vital children’s hospices services, we have moved to a three-year funding settlement. His criticism beggars belief.

• 16 Oct 2025 · Children’s Hospices: South-east England · Hansard source

  More

  The hon. Lady will know that children’s hospices are in a different situation from adult hospices: there has always been a centralised grant for children’s hospices, whereas the funding for adult hospices goes through ICBs and is part of the broader budgeting and commissioning process. Clearly, we will need to set an overall financial framework for adult hospices. We are currently going through the final stages of negotiations, both with the Treasury and within the Department of Health and Social Care, to finalise the financial envelopes and allocations for each part of my portfolio and the portfolios of my ministerial colleagues. Although the investment is important, there are big opportunities around reform. A lot more needs to be done around the early identification of people in need of palliative care and people reaching the end of life. The interface between hospitals, hospices and primary care is nowhere near where it needs to be. A big part of our neighbourhood health strategy will therefore be about how we ensure that hospices have a strong voice at the table in the holistic integrated planning that is such an important part of the journey. The hon. Lady made some powerful points about that in her speech, and we are looking at the issue as we speak. I am meeting officials to determine how to reform the system. It is not just about the money, but about how the system works. We think that there is huge room for improvement. I was truly inspired to visit Noah’s Ark children’s hospice in Barnet yesterday to understand the key issues that it is facing and see how our three-year funding commitment will support it to continue delivering essential palliative care and end-of-life care services to children and young people in its community. When I chatted to the chief executive yesterday, it was very clear how pleased she is to have some stability and certainty in planning the staffing and the services provided at Noah’s Ark. It is a wonderful place; I pay tribute to everybody who works there, and to the families. We recognise the challenges facing the palliative care and end-of-life care sector, particularly hospices. The Department and NHS England are looking at how to improve the access, quality and sustainability of all-age palliative care and end-of-life care, in line with our 10-year health plan. The Government and the NHS will closely monitor the shift towards strategic commissioning of palliative care and end-of-life care services to ensure that services reduce variation in access and quality, although some variation may be appropriate to reflect both innovation and the needs of local populations. Officials will present further proposals to me over the coming months, outlining the drivers and incentives that are required in palliative care and end-of-life care to enable the shift from hospital to community, including as part of neighbourhood health teams. Furthermore, through the National Institute for Health and Care Research, the Department is investing £3 million in a policy research unit in palliative and end-of-life care. The unit launched in January 2024 and is building the evidence base on palliative care and end-of-life care, with a specific focus on inequalities and on ironing out the regional variations to which the hon. Lady rightly pointed. I hope that those measures and our plans reassure hon. Members of this Government’s rock-solid commitment to building a sustainable palliative care and end-of-life care sector for the long term. Alongside key partners, NHS England and others will continue to engage proactively with our stakeholders, including the voluntary sector and independent hospices, to understand the issues that they face. We will continue working with NHS England in supporting ICBs to effectively commission the palliative care and end-of-life care needed by their local populations. I reiterate my thanks to the hon. Member for Mid Sussex for bringing this vital issue to the House, as well as to all hon. Members who have intervened in the debate and are passionately committed to it on behalf of their constituents. Question put and agreed to.

• 16 Oct 2025 · Children’s Hospices: South-east England · Hansard source

  More

  I thank the hon. Member for Mid Sussex (Alison Bennett) for securing this vital debate. I also thank all those who work or volunteer in the palliative care and end-of-life care sector for their care and support—the compassion that they provide to patients, families and loved ones when they need it most. This Government want a society in which every child receives high-quality, compassionate care from diagnosis through to the end of life, irrespective of condition or geographical location. In England, integrated care boards are responsible for the commissioning of palliative care and end-of-life care services to meet the needs of their local populations. To support ICBs in that duty, NHS England has published statutory guidance and service specifications. It has also developed a palliative care and end-of-life care dashboard, which brings together all relevant local data in one place. That dashboard helps commissioners to understand the palliative care and end-of-life care needs of their local population. While the majority of palliative care and end-of-life care is provided by NHS staff and services, we recognise the vital part that voluntary sector organisations, including hospices, also play in providing support to people at the end of life and their loved ones. In recognition of this, we are supporting the hospice sector with a £100 million capital funding boost for eligible adult and children and young people’s hospices in England, to ensure they have the best physical environment for care. I am pleased that the first £25 million tranche of that funding, which Hospice UK kindly allocated and distributed to hospices throughout England, was fully spent by hospices on capital projects. An additional £75 million has been transferred to Hospice UK for onward allocation to individual hospices for use in the 2025-26 financial year, and I know that many hospices are already spending that funding this year. Hospices in London and the south-east are receiving over £28 million of that £100 million capital funding. That includes over £4 million for children and young people’s hospices in London and the south-east. We are also providing £26 million in revenue funding to support children and young people’s hospices for 2025-26. This is a continuation of the funding that, until recently, was known as the children and young people’s hospice grant. Children and young people’s hospices in London and the south-east are receiving almost £8.5 million of that £26 million of revenue funding. As confirmed in my written ministerial statement laid earlier today, I am delighted and proud to be in a position to announce that we will continue that centrally administered funding for the next three years of this spending review period. That includes the 2026-27 to 2028-29 financial years, as well as 2025-26. Each year, children and young people’s hospices in England will receive at least £26 million—adjusted for inflation—from NHS England via their local ICBs. This amounts to at least £78 million over the next three years to support hospice care for children and young people, mirroring current and previous years’ transaction arrangements. By doing this, we are promoting a more consistent national approach and supporting commissioners to prioritise the palliative care and end-of-life care needs of their local population. Further details on the delivery of this funding will follow in due course. This Government’s commitment to provide that much-needed funding until the end of the spending review period recognises that the ability to plan for the long term is vital to our children and young people’s hospices. I am proud that this Government have removed the cliff edge of annual funding cycles, so that our children and young people’s hospices will now be able to operate on the basis of far greater certainty and stability.

• 15 Oct 2025 · Jhoots Pharmacy · Hansard source

  More

  I thank the hon. Lady and pay tribute to her work as Chair of the Select Committee. I am very proud of the fact that we delivered a £500 million uplift to pharmacy—19% across the two-year period. It was the highest uplift of any sector, not just of my portfolio but the entire NHS. I am also very proud of the fact that we are taking forward hub-and-spoke legislation to enable pharmacists and pharmacy technicians to operate at the top of their licence. The day before yesterday we signed off on a statutory instrument to improve the ability of technicians to do more in the area of dispensing. We are looking to empower the workforce and enable them to operate at the top of their licence. That is a fundamental part of the shift from hospital to community that is at the heart of our 10-year plan.

• 15 Oct 2025 · Jhoots Pharmacy · Hansard source

  More

  In terms of the replacement for Jhoots services, that is where we are in a Catch-22 situation, because until a pharmacy that is not providing a service has been moved out of the way, it is not possible to move in and replace that service with another, so the first step in all this is to take action against those pharmacies that are not delivering to requisite service standards. As soon as we can get that process moving, we can start to commission and bring in alternative providers. I share his frustration and the impatience of his constituents, and I assure him that we are taking urgent action on all these issues.

• 15 Oct 2025 · Jhoots Pharmacy · Hansard source

  More

  My hon. Friend rightly puts her finger on the Catch-22 situation in which we find ourselves. It is patently absurd that a pharmacy that is not operating, as she just described, is blocking the ability of others to step in and fill the gap. That is something we have to resolve, and it is part of the work I have commissioned urgently. We clearly have gaps in the regulatory framework. This is an unprecedented situation, and we are working at pace to address it, but she has rightly put her finger on this Catch-22, which needs to be resolved. We need to move one piece out of the way so that we can deal with the situation.

• 15 Oct 2025 · Jhoots Pharmacy · Hansard source

  More

  As I said, we are in constant dialogue with ICBs and the GPhC. I absolutely get it: we need to speed it up as it needs to be faster and more urgent. I am clear about that, and we are taking this forward as a matter of priority. In terms of taking action against individual directors, nothing is off the table. As I said, the regulatory framework as things stand does not facilitate that, so we have got to look at other options. But there are views in the GPhC that suggest there may be some ways of looking at interpreting regulations and legislation that could facilitate more immediate action. That is on the menu of actions that we are looking at.

• 15 Oct 2025 · Jhoots Pharmacy · Hansard source

  More

  This is absolutely urgent, as the hon. Member rightly says. I have commissioned officials to work on this matter at pace. We can clearly see that this is a matter of national significance simply by the number of colleagues in the Chamber. I can give the hon. Member that assurance, and I would be happy to update him once I have a better sense of the exact timeframe and deadlines. We will be insisting that things happen as a matter of urgency.

• 15 Oct 2025 · Jhoots Pharmacy · Hansard source

  More

  I congratulate the hon. Member on securing this important urgent question. Pharmacies play a vital role in our healthcare system. They are at the heart of our high streets and are the cornerstone of communities up and down the country. That is why this Government have given pharmacies a funding boost of almost £500 million this year, which is more than any other area of the NHS and the biggest uplift in years. Indeed, we have provided a 19% uplift over the two-year period. The vast majority of pharmacies provide excellent care to their patients, but unfortunately there are some that fall short of the standards we expect. Sadly, the services provided by Jhoots are falling well below the mark. Hon. Members will know that several integrated care boards have been deploying contract management actions against Jhoots, initially in the form of breach notices. Integrated care boards enforce the NHS terms of service on pharmacies for such things as their opening hours, and the General Pharmaceutical Council regulates pharmacy premises and pharmacy professionals. Both ICBs and the General Pharmaceutical Council have powers to address problems in pharmacies and they are actively using those powers, including in relation to stores that are part of Jhoots. I have written to the hon. Gentleman about this case. As he will understand, it is difficult for me to go into detail about one pharmacy chain, at least on the specifics of the measures we are taking, but I can tell him that where there are problems with access to medicines, ICBs are supporting affected patients in the short term, for example by allowing local dispensing doctors to provide dispensing services to those patients. Where pharmacy stores regularly breach their terms of service, ICBs can give them notice that they are being removed from the pharmaceutical list. This power applies to any and all pharmacies, including, of course, Jhoots, and means that pharmacies would no longer be able to provide NHS services. Such notices can be appealed against, so it does take some time to work through the system. I stress to hon. Members that pharmacies are private businesses and must be responsible business owners. We can regulate what pharmacies should and should not do as part of their NHS terms of service, but it is not possible to prevent pharmacies from, for example, not paying their staff. In conclusion, if pharmacies breach their terms of service, for example by not being open when they should be or where there are patient safety concerns, we take action. The General Pharmaceutical Council is taking regulatory action. ICBs are taking regulatory action and are supporting patients with access to medicines where necessary. This is aimed at improving pharmacies’ behaviour, but can ultimately lead to pharmacies being forced to close their business. I have also asked my officials to explore whether we can strengthen the regulatory framework to be able to deal more quickly with pharmacies that do not play by the rules. My officials are working on that as a matter of urgency. My office is also setting up a meeting with the hon. Gentleman to discuss this matter further and I will keep the House updated in the usual way.

• 15 Oct 2025 · Jhoots Pharmacy · Hansard source

  More

  I know that my colleague the Minister of State for Health is working hard on the drafting process for the Bill. I cannot give the hon. Member the exact date of its introduction, but I would be very happy to write to him with confirmation of the expected introduction date.

• 15 Oct 2025 · Jhoots Pharmacy · Hansard source

  More

  I thank the shadow Minister for his questions. He asked about first awareness of what was happening with Jhoots. He will be aware that it entered the market through the purchase of a number of Lloyds pharmacies that were no longer a going concern in 2023, so the question about due diligence on Jhoots as an operator is probably something he should be asking one of my predecessors from his party, which was in power at the time. Since those purchases, Jhoots has expanded rapidly, and that has been where we have seen the question marks around its ability to operate and the serious downgrading of services. I have not met the management of Jhoots. We are looking at a whole range of legal and regulatory enforcement procedures, and the decision we have taken is that it is better not to interfere in any way in those processes, but I am certainly monitoring that very closely. If we receive legal advice that suggests that such a meeting would be a good idea, I will of course be open to it. However, the current legal position based on the advice we have received is that it would not be appropriate at this time. On local pharmacy access, integrated care boards have a statutory responsibility to ensure adequate pharmacy provision. Some ICBs, for example, have allowed dispensing GP practices to provide dispensing services to affected patients, while others have worked with local GP practices to advise patients to nominate alternative nearby pharmacies for their prescriptions. We have looked at the impact geographically, and our view is that in most cases there is alternative pharmacy provision to Jhoots within striking distance. However, there are four or five areas of the country where that is not the case, including in the constituency of the hon. Member for West Dorset (Edward Morello), who secured this urgent question. I am very conscious of that. In those cases, extra provision needs to be made through ICBs and GPs—that may be through distance selling or by other means—to ensure that patients have pharmacy access. The shadow Minister asks about continuity of care and national contingency. The situation is challenging because, as I mentioned in my remarks and as officials have said, we have not seen this rapid decline in service before. We are working at pace to strengthen the regulatory framework and we are looking at contingency plans. I do not see any reason why the overall funding settlement for pharmacy should be undermined. We will continue to protect community pharmacy as a crucial part of our NHS.